These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 17115449)
1. A simplified bioprocess for human alpha-fetoprotein production from inclusion bodies. Leong SS; Middelberg AP Biotechnol Bioeng; 2007 May; 97(1):99-117. PubMed ID: 17115449 [TBL] [Abstract][Full Text] [Related]
2. Adsorptive refolding of a highly disulfide-bonded inclusion body protein using anion-exchange chromatography. Chen Y; Leong SS J Chromatogr A; 2009 Jun; 1216(24):4877-86. PubMed ID: 19419725 [TBL] [Abstract][Full Text] [Related]
3. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli. Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102 [TBL] [Abstract][Full Text] [Related]
4. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli. Tan H; Dan G; Gong H; Cao L Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260 [TBL] [Abstract][Full Text] [Related]
5. Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli. Sharma K; Babu PV; Sasidhar P; Srinivas VK; Mohan VK; Krishna E Protein Expr Purif; 2008 Jul; 60(1):7-14. PubMed ID: 18430585 [TBL] [Abstract][Full Text] [Related]
6. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration. Vallejo LF; Rinas U Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801 [TBL] [Abstract][Full Text] [Related]
7. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli. Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889 [TBL] [Abstract][Full Text] [Related]
8. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli. Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894 [TBL] [Abstract][Full Text] [Related]
9. Expression, renaturation and simultaneous purification of recombinant human stem cell factor in Escherichia coli. Lili W; Chaozhan W; Xindu G Biotechnol Lett; 2006 Jul; 28(13):993-7. PubMed ID: 16786266 [TBL] [Abstract][Full Text] [Related]
10. Engineering of the Saccharomyces cerevisiae yeast strain with multiple chromosome-integrated genes of human alpha-fetoprotein and its high-yield secretory production, purification, structural and functional characterization. Dudich E; Dudich I; Semenkova L; Benevolensky S; Morozkina E; Marchenko A; Zatcepin S; Dudich D; Soboleva G; Khromikh L; Roslovtceva O; Tatulov E Protein Expr Purif; 2012 Jul; 84(1):94-107. PubMed ID: 22561245 [TBL] [Abstract][Full Text] [Related]
11. [Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist]. Li S; Deng X; Zhao H; Huang X; Yu T; Cheng Y; Dan G Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1128-32. PubMed ID: 18027711 [TBL] [Abstract][Full Text] [Related]
12. Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies. Medynski D; Tuan M; Liu W; Wu S; Lin X Protein Expr Purif; 2007 Apr; 52(2):395-402. PubMed ID: 17126563 [TBL] [Abstract][Full Text] [Related]
13. Factors affecting protein refolding yields in a fed-batch and batch-refolding system. Mannall GJ; Titchener-Hooker NJ; Dalby PA Biotechnol Bioeng; 2007 Aug; 97(6):1523-34. PubMed ID: 17304557 [TBL] [Abstract][Full Text] [Related]
14. Production of enzymatically active ketosteroid isomerase following insoluble expression in Escherichia coli. Hutchinson MH; Morreale G; Middelberg AP; Chase HA Biotechnol Bioeng; 2006 Nov; 95(4):724-33. PubMed ID: 16897731 [TBL] [Abstract][Full Text] [Related]
15. Chromatographic methods for the isolation of, and refolding of proteins from, Escherichia coli inclusion bodies. Gu Z; Weidenhaupt M; Ivanova N; Pavlov M; Xu B; Su ZG; Janson JC Protein Expr Purif; 2002 Jun; 25(1):174-9. PubMed ID: 12071713 [TBL] [Abstract][Full Text] [Related]
16. [Renaturation, purification and antigenicity identification of recombinant protein of Cysticercus cellulosae expressed in Escherichia coli]. Zhang S; Jia W; Luo X; Jing Z; Wu G; Zheng Y; Guo A; Cai X Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1490-5. PubMed ID: 18998557 [TBL] [Abstract][Full Text] [Related]
17. Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies. Kischnick S; Weber B; Verdino P; Keller W; Sanders EA; Anspach FB; Fiebig H; Cromwell O; Suck R Protein Expr Purif; 2006 Jun; 47(2):621-8. PubMed ID: 16495080 [TBL] [Abstract][Full Text] [Related]
18. High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications. Pizarro SA; Gunson J; Field MJ; Dinges R; Khoo S; Dalal M; Lee M; Kaleas KA; Moiseff K; Garnick S; Reilly DE; Laird MW; Schmelzer CH Protein Expr Purif; 2010 Aug; 72(2):184-93. PubMed ID: 20302942 [TBL] [Abstract][Full Text] [Related]
19. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies. Cabrita LD; Bottomley SP Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702 [TBL] [Abstract][Full Text] [Related]
20. Intensified process for the purification of an enzyme from inclusion bodies using integrated expanded bed adsorption and refolding. Hutchinson MH; Chase HA Biotechnol Prog; 2006; 22(4):1187-93. PubMed ID: 16889397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]